← Back to Search

Behavioural Intervention

AI-Powered Device for Chronic Insomnia in Cancer Survivors

N/A
Recruiting
Research Sponsored by Medstar Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days
Awards & highlights

Study Summary

This trial is testing an AI-powered device to help young adult cancer survivors with chronic sleep disorders using cognitive behavioral therapy. #CBTI #VAVA #SleepDisorders

Who is the study for?
This trial is for young adult cancer survivors aged 18-29 who suffer from chronic insomnia. Participants must have a history of any type or stage of cancer and an internet router at home. They should be experiencing less sleep than recommended for their age over the past 3 months. Those with acute medical/psychiatric disorders, developmental disorders, or a life expectancy under 12 months cannot join.Check my eligibility
What is being tested?
The study is testing the VAVA prototype, a voice-activated virtual assistant designed to deliver Cognitive Behavioral Therapy for Insomnia (CBT-I). The goal is to see if this device can help improve sleep among young adults who survived cancer and are struggling with chronic sleep issues.See study design
What are the potential side effects?
Since the intervention involves using a virtual assistant device to provide therapy, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Feasibility of device use

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention armExperimental Treatment1 Intervention
Participants (N=15) will will be provided with the VAVA prototype along with installation instructions to embed the VAVA within their homes. We provide them with a smart speaker running our intervention, a smart lamp, and a new router. They will be asked to trial the VAVA for a period of 2 weeks, a duration consistent with the primary stage of CBT-I treatment.

Find a Location

Who is running the clinical trial?

Medstar Health Research InstituteLead Sponsor
189 Previous Clinical Trials
115,558 Total Patients Enrolled

Media Library

VAVA prototype (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05875129 — N/A
Cancer Research Study Groups: Intervention arm
Cancer Clinical Trial 2023: VAVA prototype Highlights & Side Effects. Trial Name: NCT05875129 — N/A
VAVA prototype (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05875129 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative open to individuals aged 45 and older?

"The requirements for enrolment in this clinical trial specifies the minimum age of consent and a maximum age limit of 29 years old."

Answered by AI

Is there an eligibility criterion that would permit me to join this medical experiment?

"Patients suffering from cancer and aged 18-29 may be accepted into this trial, with a maximum of 15 eligible participants."

Answered by AI

Are enrollment opportunities still available for this medical experiment?

"Clinicaltrials.gov records that this medical trial is not presently taking on new participants; the study was initially posted June 1st 2023, and edited most recently May 22nd 2023. Nonetheless, there are 737 other studies actively recruiting patients at present time."

Answered by AI
~9 spots leftby Apr 2025